A NeuroMuse GmbH Technology Transfer Project
Project M.
A topical-product development project for Jordan, North Africa & the Gulf
A technology-transfer opportunity for pharmaceutical partners.
The Opportunity
A development concept. A regional partnership.
Project M explores a topical product based on a quaternary ammonium compound for Jordan, North Africa (Morocco, Algeria, Tunisia, Libya, Egypt) and the Gulf states. We seek a regional pharmaceutical partner to assess the technical evidence, confirm the appropriate regulatory classification and develop a market-specific pathway.
What we offer
Development
Three development options
Options subject to evidence, classification and local authority decisions.
Option 1 · Care concept
Assess a care-spray concept only where its formulation, intended use and claims fit the applicable local category. No fast-track or launch date is promised.
Option 2 · Wound-care assessment
Explore the appropriate route for a wound-care concept. A medical-device pathway is conditional on lawful classification, including the principal mode of action, and is not assumed.
Option 3 · Medicine development
Evaluate a medicinal-product dossier, required studies and authorisation. Other dosage forms would need separate development and applicable approvals.
Regional Partnership
Shared expertise. Local reach.
We are looking for a strong regional pharmaceutical partner for registration, manufacturing or distribution, and marketing.
"We are open to discussions with qualified pharmaceutical partners in the region."
Start a Conversation
Let's explore a regional partnership.
Start with a non-confidential introduction. Detailed information is shared only after an agreed NDA; contacting us does not itself create confidentiality obligations. The contact link opens your email application. Please do not send health information.